-
1
-
-
9144253900
-
Treatment of lentigo maligna with topical imiquimod
-
Naylor MF, Crowson N, Kuwahara R, et al. Treatment of lentigo maligna with topical imiquimod. Br J Dermatol. 2003;149(Suppl 66):66-70.
-
(2003)
Br J Dermatol
, vol.149
, Issue.SUPPL. 66
, pp. 66-70
-
-
Naylor, M.F.1
Crowson, N.2
Kuwahara, R.3
-
2
-
-
0842330526
-
Topical imiquimod immunotherapy in the management of lentigo maligna
-
Powell AM, Russell-Jones R, Barlow RJ. Topical imiquimod immunotherapy in the management of lentigo maligna. Clin Exp Dermatol. 2004;29:15-21.
-
(2004)
Clin Exp Dermatol
, vol.29
, pp. 15-21
-
-
Powell, A.M.1
Russell-Jones, R.2
Barlow, R.J.3
-
3
-
-
17444378895
-
Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod
-
Wolf IH, Cerroni L, Kodama K, Kerl H. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod. Arch Dermatol. 2005;141:510-514.
-
(2005)
Arch Dermatol
, vol.141
, pp. 510-514
-
-
Wolf, I.H.1
Cerroni, L.2
Kodama, K.3
Kerl, H.4
-
4
-
-
33947397974
-
Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 Case reports
-
Spenny ML, Walford J, Werchniak AE, et al. Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports. Cutis. 2007;79:149-152.
-
(2007)
Cutis
, vol.79
, pp. 149-152
-
-
Spenny, M.L.1
Walford, J.2
Werchniak, A.E.3
-
6
-
-
33748900927
-
The role of topical immune response modifiers in skin cancer
-
Woodmansee C, Pillow J, Skinner RB Jr. The role of topical immune response modifiers in skin cancer. Drugs. 2006;66:1657-1664.
-
(2006)
Drugs
, vol.66
, pp. 1657-1664
-
-
Woodmansee, C.1
Pillow, J.2
Skinner Jr., R.B.3
-
7
-
-
41549087844
-
Advances in the use of topical imiquimod to treat dermatologic disorders
-
Lacarrubba F, Nasca MR, Micali G. Advances in the use of topical imiquimod to treat dermatologic disorders. Ther Clin Risk Manag. 2008;4:87-97
-
(2008)
Ther Clin Risk Manag
, vol.4
, pp. 87-97
-
-
Lacarrubba, F.1
Nasca, M.R.2
Micali, G.3
-
8
-
-
0038377360
-
Possible application of videodermatoscopy beyond pigmented lesions
-
Micali G, Lacarrubba F. Possible application of videodermatoscopy beyond pigmented lesions. Int J Dermatol 2003;42:430-433
-
(2003)
Int J Dermatol
, vol.42
, pp. 430-433
-
-
Micali, G.1
Lacarrubba, F.2
-
10
-
-
14844317609
-
Dermoscopy for early detection of facial lentigo maligna
-
Stante M, Giorgi V, Stanganelli I, et al. Dermoscopy for early detection of facial lentigo maligna. Br J Dermatol. 2005;152:361-364.
-
(2005)
Br J Dermatol
, vol.152
, pp. 361-364
-
-
Stante, M.1
Giorgi, V.2
Stanganelli, I.3
-
11
-
-
2342467450
-
Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy
-
Powell AM, Russell-Jones R. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy. J Am Acad Dermatol. 2004;50:792-796.
-
(2004)
J Am Acad Dermatol
, vol.50
, pp. 792-796
-
-
Powell, A.M.1
Russell-Jones, R.2
-
12
-
-
34247527414
-
Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream
-
van Meurs T, van Doorn R, Kirtschig G. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. Dermatol Surg. 2007;33:623-626.
-
(2007)
Dermatol Surg
, vol.33
, pp. 623-626
-
-
Van Meurs, T.1
Van Doorn, R.2
Kirtschig, G.3
-
13
-
-
4544357363
-
A pilot study of treatment of lentigo maligna with 5% imiquimod cream
-
Fleming CJ, Bryden AM, Evans A, et al. A pilot study of treatment of lentigo maligna with 5% imiquimod cream. Br J Dermatol. 2004;151:485-488.
-
(2004)
Br J Dermatol
, vol.151
, pp. 485-488
-
-
Fleming, C.J.1
Bryden, A.M.2
Evans, A.3
-
14
-
-
33748454894
-
Imiquimod in the treatment of lentigo maligna
-
Rajpar SF, Marsden JR. Imiquimod in the treatment of lentigo maligna. Br J Dermatol. 2006;55:653-656.
-
(2006)
Br J Dermatol
, vol.55
, pp. 653-656
-
-
Rajpar, S.F.1
Marsden, J.R.2
-
15
-
-
33646082988
-
Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna
-
Micantonio T, Fargnoli MC, Peris K. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna. Arch Dermatol. 2006;142:530-531.
-
(2006)
Arch Dermatol
, vol.142
, pp. 530-531
-
-
Micantonio, T.1
Fargnoli, M.C.2
Peris, K.3
-
16
-
-
55949091086
-
Lentigo maligna managed with topical imiquimod and dermoscopy: Report of two cases
-
Epub ahead of print
-
de Troya-Martín M, Frieyro-Elicegui M, Liébana RF, et al. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases. Dermatol Surg. 2008 [Epub ahead of print].
-
(2008)
Dermatol Surg
-
-
De Troya-Martín, M.1
Frieyro-Elicegui, M.2
Liébana, R.F.3
-
17
-
-
0041307296
-
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease
-
Fisher GH, Lang PG. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Arch Dermatol. 2003;39:945-947.
-
(2003)
Arch Dermatol
, vol.39
, pp. 945-947
-
-
Fisher, G.H.1
Lang, P.G.2
|